These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 28886871)

  • 1. DAF in diabetic patients is subject to glycation/inactivation at its active site residues.
    Flückiger R; Cocuzzi E; Nagaraj RH; Shoham M; Kern TS; Medof ME
    Mol Immunol; 2018 Jan; 93():246-252. PubMed ID: 28886871
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chromatographic quantification of argpyrimidine, a methylglyoxal-derived product in tissue proteins: comparison with pentosidine.
    Wilker SC; Chellan P; Arnold BM; Nagaraj RH
    Anal Biochem; 2001 Mar; 290(2):353-8. PubMed ID: 11237339
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Non-enzymic glycation of fibrous collagen: reaction products of glucose and ribose.
    Bailey AJ; Sims TJ; Avery NC; Halligan EP
    Biochem J; 1995 Jan; 305 ( Pt 2)(Pt 2):385-90. PubMed ID: 7832750
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pyrogallol experimentally and theoretically suppressed advanced glycation end products (AGEs) formation, as one of the mechanisms involved in the chronic complications of the diabetes.
    Dorali Beni A; Bahramikia S
    J Asian Nat Prod Res; 2024 Jun; 26(6):726-738. PubMed ID: 38006229
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure-based mapping of DAF active site residues that accelerate the decay of C3 convertases.
    Kuttner-Kondo L; Hourcade DE; Anderson VE; Muqim N; Mitchell L; Soares DC; Barlow PN; Medof ME
    J Biol Chem; 2007 Jun; 282(25):18552-18562. PubMed ID: 17395591
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Conservation in decay accelerating factor (DAF) structure among primates.
    Kuttner-Kondo L; Subramanian VB; Atkinson JP; Yu J; Medof ME
    Dev Comp Immunol; 2000 Dec; 24(8):815-27. PubMed ID: 10906393
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of the active sites in decay-accelerating factor.
    Kuttner-Kondo LA; Mitchell L; Hourcade DE; Medof ME
    J Immunol; 2001 Aug; 167(4):2164-71. PubMed ID: 11490001
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure/function studies of human decay-accelerating factor.
    Brodbeck WG; Kuttner-Kondo L; Mold C; Medof ME
    Immunology; 2000 Sep; 101(1):104-11. PubMed ID: 11012760
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Advanced glycation end product ligands for the receptor for advanced glycation end products: biochemical characterization and formation kinetics.
    Valencia JV; Weldon SC; Quinn D; Kiers GH; DeGroot J; TeKoppele JM; Hughes TE
    Anal Biochem; 2004 Jan; 324(1):68-78. PubMed ID: 14654047
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular modeling and mechanism of action of human decay-accelerating factor.
    Kuttner-Kondo L; Medof ME; Brodbeck W; Shoham M
    Protein Eng; 1996 Dec; 9(12):1143-9. PubMed ID: 9010927
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Maillard reactions by alpha-oxoaldehydes: detection of glyoxal-modified proteins.
    Sady C; Jiang CL; Chellan P; Madhun Z; Duve Y; Glomb MA; Nagaraj RH
    Biochim Biophys Acta; 2000 Sep; 1481(2):255-64. PubMed ID: 11018716
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assay of advanced glycation endproducts (AGEs): surveying AGEs by chromatographic assay with derivatization by 6-aminoquinolyl-N-hydroxysuccinimidyl-carbamate and application to Nepsilon-carboxymethyl-lysine- and Nepsilon-(1-carboxyethyl)lysine-modified albumin.
    Ahmed N; Argirov OK; Minhas HS; Cordeiro CA; Thornalley PJ
    Biochem J; 2002 May; 364(Pt 1):1-14. PubMed ID: 11988070
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chromatographic assay of glycation adducts in human serum albumin glycated in vitro by derivatization with 6-aminoquinolyl-N-hydroxysuccinimidyl-carbamate and intrinsic fluorescence.
    Ahmed N; Thornalley PJ
    Biochem J; 2002 May; 364(Pt 1):15-24. PubMed ID: 11988071
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of advanced glycation end products and carbonyl compounds in patients with different conditions of oxidative stress.
    Lapolla A; Reitano R; Seraglia R; Sartore G; Ragazzi E; Traldi P
    Mol Nutr Food Res; 2005 Jul; 49(7):685-90. PubMed ID: 15926142
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decay-accelerating factor must bind both components of the complement alternative pathway C3 convertase to mediate efficient decay.
    Harris CL; Pettigrew DM; Lea SM; Morgan BP
    J Immunol; 2007 Jan; 178(1):352-9. PubMed ID: 17182573
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Complement-mediated clearance of erythrocytes: mechanism and delineation of the regulatory roles of Crry and DAF. Decay-accelerating factor.
    Molina H; Miwa T; Zhou L; Hilliard B; Mastellos D; Maldonado MA; Lambris JD; Song WC
    Blood; 2002 Dec; 100(13):4544-9. PubMed ID: 12393518
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Formation of Pentosidine Cross-Linking in Myoglobin by Glyoxal: Detection of Fluorescent Advanced Glycation End Product.
    Banerjee S
    J Fluoresc; 2017 Jul; 27(4):1213-1219. PubMed ID: 28299531
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Delta-short consensus repeat 4-decay accelerating factor (DAF: CD55) inhibits complement-mediated cytolysis but not NK cell-mediated cytolysis.
    Miyagawa S; Kubo T; Matsunami K; Kusama T; Beppu K; Nozaki H; Moritan T; Ahn C; Kim JY; Fukuta D; Shirakura R
    J Immunol; 2004 Sep; 173(6):3945-52. PubMed ID: 15356143
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pigs express multiple forms of decay-accelerating factor (CD55), all of which contain only three short consensus repeats.
    Pérez de la Lastra JM; Harris CL; Hinchliffe SJ; Holt DS; Rushmere NK; Morgan BP
    J Immunol; 2000 Sep; 165(5):2563-73. PubMed ID: 10946283
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure and function of decay accelerating factor CD55.
    Nicholson-Weller A; Wang CE
    J Lab Clin Med; 1994 Apr; 123(4):485-91. PubMed ID: 7511675
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.